Sector | Trading | Compare with Sector peers |
Industry | Trading | Compare with Industry peers |
Website | http://www.zenlabsethica.com | |
Market Cap | 27.02 Cr. | |
Enterprise Value(EV) | 31.01 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.19 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 64.38 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 15.31 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 2.71 | Calculated using Price: 41.50 |
Dividend Yield | 0.60 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.65 Cr. | 6,510,015 Shares |
FaceValue | 10 | |
About Zenlabs Ethica Ltd. | ||
Zenlabs Ethica is one of the leading marketing companies and in collaboration with Zenlabs Pharmaceutical Inc, Canada, the company develops and markets a wide range of quality, affordable and branded drugs. |
1 Day |
|
-0.48% |
1 Week |
|
+3.65% |
1 Month |
|
-12.08% |
3 Month |
|
+2.72% |
6 Month |
|
+15.09% |
1 Year |
|
-33.18% |
2 Year |
|
+42.86% |
5 Year |
|
-19.57% |
10 Year |
|
+481.23% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -3.31 | 5.04 | 17.99 | 18.18 | 16.53 | -11.05 | 9.61 | 8.74 | 5.14 | |
Return on Capital Employed (%) | -3 | 2.9 | 21.03 | 23.85 | 23.44 | -11.27 | 13.77 | 16.21 | 10.34 | |
Return on Assets (%) | -1.76 | 1 | 2.99 | 3.69 | 3.91 | -2.53 | 2.35 | 2.25 | 1.21 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 2 | 5 | 6 | 7 | 8 | 7 | 9 | 9 | 10 | 10 | |
Non Curr. Liab. | 0 | 1 | 1 | 0 | 1 | 0 | 2 | 3 | 4 | 3 | |
Curr. Liab. | 2 | 25 | 27 | 22 | 26 | 26 | 21 | 25 | 29 | 26 | |
Minority Int. | |||||||||||
Equity & Liab. | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 43 | 39 | |
Non Curr. Assets | 3 | 3 | 3 | 2 | 2 | 2 | 4 | 4 | 6 | 5 | |
Curr. Assets | 1 | 27 | 31 | 28 | 33 | 32 | 27 | 33 | 38 | 34 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 4 | 30 | 33 | 30 | 35 | 34 | 32 | 38 | 43 | 39 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | 58 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Total Income | 16 | 81 | 72 | 67 | 60 | 57 | 69 | 67 | 58 | ||
Total Expenditure | 0 | -16 | -80 | -70 | -65 | -61 | -55 | -67 | -64 | -56 | |
PBIDT | 0 | 0 | 2 | 2 | 2 | -1 | 2 | 2 | 3 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | ||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 | -1 | |
Taxation | 0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | 0 | -1 | -1 | ||||||||
PAT | 0 | 0 | 1 | 1 | 1 | -1 | 1 | 1 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 1 | 2 | 2 | -1 | 1 | 1 | 1 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 1 | -1 | 0 | 1 | 0 | -8 | 0 | 2 | |
Cash Fr. Inv. | -2 | 0 | 0 | 0 | 0 | 0 | -1 | ||||
Cash Fr. Finan. | 3 | 0 | 0 | 0 | 0 | -1 | 0 | 0 | |||
Net Change | 0 | 0 | 2 | -1 | 0 | 0 | 0 | -9 | 0 | 0 | |
Cash & Cash Eqvt | 0 | 2 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
Tue, 26 Mar 2024
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Hitesh Popatlal Oswal |
Tue, 26 Mar 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Preet Remedies Ltd |
Wed, 20 Mar 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate Intimation regarding Loss of Share Certificate as per Reg 39(3) of SEBI (LODR) Regulations 2015 |
Thu, 28 Mar 2024 |
Opening at High |
Opening at High for 3 days |
Making Lower Lows for 3 days |
Close Below Last Month Low |
Opening at High for 2 Days |